Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Pharmarise Holdings Corp    2796   JP3802320006

PHARMARISE HOLDINGS CORP (2796)
Mes dernières consult.
Most popular
  Report  
No quotes available
-- JPY   --.--%
2017PHARMARISE : to Acquire 100% Stake in Mythos
AQ
SummaryChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets

Pharmarise : to Acquire 100% Stake in Mythos

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/09/2017 | 12:36pm CET
Deal Type: Acquisition
Deal Sub Type: 100% Acquisition
Deal Country: Japan
Deal Status: Announced
Deal Value: 2.7603 Million USD

Deal in Brief

Pharmarise Holdings Corporation, an operator of pharmacy stores, has agreed to acquire all shares in Mythos Co., Ltd., a provider of customer relationship management (CRM) software systems and cloud-based business services to the pharmaceutical companies, for JPY302 million (USD2.76 million). Both the companies are based in Japan. The transaction is effective from June 30, 2017.

Index - Pharmacy
Index - Drug Stores and Pharmacies
Index - Customer Relationship Management
Index - Japan

(c) 2017 Progressive Media Group Metadata. All rights reserved. Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Progressive Media Group Metadata shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon., source PDM Deals

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PHARMARISE HOLDINGS CORP
2017PHARMARISE : to Acquire 100% Stake in Mythos
AQ
More news
Chart PHARMARISE HOLDINGS CORP
Duration : Period :
Pharmarise Holdings Corp Technical Analysis Chart | 2796 | JP3802320006 | 4-Traders
Income Statement Evolution
Managers
NameTitle
Toshimichi Ohno Chairman & Chief Executive Officer
Tetsuo Iwasaki Executive President, COO & Representative Director
Masayuki Akiyama Senior Manager Director & GM-Business Promotion
Tetsuo Onaka Independent Director
Norio Watanabe Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PHARMARISE HOLDINGS CORP0.00%52
RAIA DROGASIL-10.78%8 368
PALTAC CORP1.91%3 170
AIN HOLDINGS INC3.56%2 255
RITE AID CORPORATION8.12%2 156
PETMED EXPRESS INC-0.59%966